Rossmore Private Capital Reduces Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Rossmore Private Capital lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.3% during the third quarter, Holdings Channel reports. The firm owned 5,860 shares of the healthcare conglomerate’s stock after selling 20 shares during the period. Rossmore Private Capital’s holdings in UnitedHealth Group were worth $3,426,000 as of its most recent SEC filing.

Other hedge funds have also recently modified their holdings of the company. Souders Financial Advisors lifted its holdings in shares of UnitedHealth Group by 0.5% in the 3rd quarter. Souders Financial Advisors now owns 11,521 shares of the healthcare conglomerate’s stock valued at $6,736,000 after purchasing an additional 60 shares during the last quarter. Community Bank & Trust Waco Texas grew its position in shares of UnitedHealth Group by 1.5% during the third quarter. Community Bank & Trust Waco Texas now owns 14,023 shares of the healthcare conglomerate’s stock worth $8,199,000 after acquiring an additional 213 shares during the last quarter. Empower Advisory Group LLC boosted its stake in UnitedHealth Group by 2.1% during the 3rd quarter. Empower Advisory Group LLC now owns 235,841 shares of the healthcare conglomerate’s stock worth $137,892,000 after purchasing an additional 4,929 shares during the period. Accredited Investors Inc. increased its stake in UnitedHealth Group by 9,235.4% in the third quarter. Accredited Investors Inc. now owns 784,924 shares of the healthcare conglomerate’s stock valued at $458,929,000 after purchasing an additional 776,516 shares during the period. Finally, Aptus Capital Advisors LLC grew its holdings in shares of UnitedHealth Group by 17.6% during the third quarter. Aptus Capital Advisors LLC now owns 62,292 shares of the healthcare conglomerate’s stock worth $36,421,000 after buying an additional 9,330 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Down 1.6 %

Shares of NYSE UNH opened at $615.01 on Wednesday. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The stock has a market capitalization of $565.98 billion, a PE ratio of 40.07, a P/E/G ratio of 1.84 and a beta of 0.58. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a fifty day moving average of $582.95 and a 200-day moving average of $547.62.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The business had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. During the same quarter in the previous year, the business earned $6.56 EPS. The company’s revenue for the quarter was up 9.2% on a year-over-year basis. On average, analysts anticipate that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be given a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.37%. The ex-dividend date is Monday, December 9th. UnitedHealth Group’s payout ratio is 54.72%.

Analyst Ratings Changes

Several equities research analysts have recently commented on UNH shares. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Tuesday. Cantor Fitzgerald boosted their price target on shares of UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 16th. Robert W. Baird increased their target price on UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 17th. Truist Financial reaffirmed a “buy” rating and set a $625.00 price objective (down previously from $640.00) on shares of UnitedHealth Group in a report on Wednesday, October 16th. Finally, Wells Fargo & Company lifted their price objective on UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. Three analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average price target of $615.53.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.